From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability-Reference-Cited by-同舟云学术

From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Published:2019-06 Issue: Volume:12 Page:100136
ISSN:2352-5541
Container-title:Sustainable Chemistry and Pharmacy
language:en
Short-container-title:Sustainable Chemistry and Pharmacy

Author:

Kümmerer Klaus

Funder

Deutsche Bundesstiftung Umwelt

GSF

Bundesministerium for Bildung und Forschung

Publisher

Elsevier BV

Subject

Management, Monitoring, Policy and Law,Pharmaceutical Science,Pollution,Environmental Chemistry

Reference22 articles.

1. Accumulation of Pharmaceuticals, Enterococcus, and Resistance Genes in Soils Irrigated with Wastewater for Zero to 100 Years in Central Mexico

2. EU, 2015. Communication from the Commission to the European Parliament and the Council. The Water Framework Directive and the Floods Directive: Actions towards the 'good status' of EU water and to reduce flood risks, COM/2015/0120 final, 9 March 2015.

3. On the way to greener ionic liquids: identification of a fully mineralizable phenylalanine-based ionic liquid

4. Methadone Contributes to N-Nitrosodimethylamine Formation in Surface Waters and Wastewaters during Chloramination

5. A path to clean water

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Earth as a Living Organism: Contribution of Integrative Medicine to the Healing of Our Planet (One Health);Complementary Medicine Research;2024-07-26

2. Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives;International Journal of Molecular Sciences;2024-05-27

3. Learning from Safe-by-Design for Safe-and-Sustainable-by-Design: Mapping the current landscape of Safe-by-Design reviews, case studies, and frameworks;Environment International;2024-01

4. Sustainable Practices in the Pharmaceutical Industry: Development and Adoption;World Sustainability Series;2024

5. Natural Compounds Used in Targeting Cellular Organelles for Drug Delivery;Interdisciplinary Cancer Research;2024